Trial Outcomes & Findings for Clinical Comparison of 2 Daily Disposable Contact Lenses - Pilot Study 1 (NCT NCT04527978)
NCT ID: NCT04527978
Last Updated: 2021-11-23
Results Overview
Distance VA was assessed with study lenses in place. VA was collected for each eye separately using logarithmic of the Minimum Angle of Resolution (logMAR) charts. A logMAR acuity of 0.0 corresponds to 20/20 Snellen acuity (normal visual acuity), with a negative value denoting better than 20/20 visual acuity. No formal hypothesis was predefined for the primary endpoint. No inferential testing was performed.
COMPLETED
NA
56 participants
Day 8 (-0/+3 days) after 10 (-2/+6) hours of wear, each study lens type
2021-11-23
Participant Flow
Subjects were recruited from 4 investigative sites located in the United States.
Of the 56 subjects enrolled in the study, 1 subject was discontinued after randomization and prior to exposure to the study lenses. This reporting group includes all randomized and exposed subjects (55).
Unit of analysis: eyes
Participant milestones
| Measure |
PRECISION1, Then Biotrue ONEday
Verofilcon A contact lenses worn first, with nesofilcon A contact lenses worn second, as randomized. Each study lens type was worn bilaterally (in both eyes) for 8 -0/+3 days in a daily disposable modality.
|
Biotrue ONEday, Then PRECISION1
Nesofilcon A contact lenses worn first, with verofilcon A contact lenses worn second, as randomized. Each study lens type was worn bilaterally (in both eyes) for 8 -0/+3 days in a daily disposable modality.
|
|---|---|---|
|
First Wear Period (8 -0/+3 Days)
STARTED
|
27 54
|
28 56
|
|
First Wear Period (8 -0/+3 Days)
COMPLETED
|
26 52
|
28 56
|
|
First Wear Period (8 -0/+3 Days)
NOT COMPLETED
|
1 2
|
0 0
|
|
Second Wear Period (8 -0/+3 Days)
STARTED
|
26 52
|
28 56
|
|
Second Wear Period (8 -0/+3 Days)
COMPLETED
|
26 52
|
28 56
|
|
Second Wear Period (8 -0/+3 Days)
NOT COMPLETED
|
0 0
|
0 0
|
Reasons for withdrawal
| Measure |
PRECISION1, Then Biotrue ONEday
Verofilcon A contact lenses worn first, with nesofilcon A contact lenses worn second, as randomized. Each study lens type was worn bilaterally (in both eyes) for 8 -0/+3 days in a daily disposable modality.
|
Biotrue ONEday, Then PRECISION1
Nesofilcon A contact lenses worn first, with verofilcon A contact lenses worn second, as randomized. Each study lens type was worn bilaterally (in both eyes) for 8 -0/+3 days in a daily disposable modality.
|
|---|---|---|
|
First Wear Period (8 -0/+3 Days)
Adverse Event
|
1
|
0
|
Baseline Characteristics
Clinical Comparison of 2 Daily Disposable Contact Lenses - Pilot Study 1
Baseline characteristics by cohort
| Measure |
PRECISION1, Then Biotrue ONEday
n=27 Participants
Verofilcon A contact lenses worn first, with nesofilcon A contact lenses worn second, as randomized. Each study lens type was worn bilaterally (in both eyes) for 8 -0/+3 days in a daily disposable modality.
|
Biotrue ONEday, Then PRECISION1
n=28 Participants
Nesofilcon A contact lenses worn first, with verofilcon A contact lenses worn second, as randomized. Each study lens type was worn bilaterally (in both eyes) for 8 -0/+3 days in a daily disposable modality.
|
Total
n=55 Participants
Total of all reporting groups
|
|---|---|---|---|
|
Age, Continuous
|
33.7 years
STANDARD_DEVIATION 6.3 • n=99 Participants
|
34.3 years
STANDARD_DEVIATION 8.9 • n=107 Participants
|
34.0 years
STANDARD_DEVIATION 7.7 • n=206 Participants
|
|
Sex: Female, Male
Female
|
20 Participants
n=99 Participants
|
25 Participants
n=107 Participants
|
45 Participants
n=206 Participants
|
|
Sex: Female, Male
Male
|
7 Participants
n=99 Participants
|
3 Participants
n=107 Participants
|
10 Participants
n=206 Participants
|
|
Ethnicity (NIH/OMB)
Hispanic or Latino
|
3 Participants
n=99 Participants
|
1 Participants
n=107 Participants
|
4 Participants
n=206 Participants
|
|
Ethnicity (NIH/OMB)
Not Hispanic or Latino
|
24 Participants
n=99 Participants
|
27 Participants
n=107 Participants
|
51 Participants
n=206 Participants
|
|
Ethnicity (NIH/OMB)
Unknown or Not Reported
|
0 Participants
n=99 Participants
|
0 Participants
n=107 Participants
|
0 Participants
n=206 Participants
|
|
Race (NIH/OMB)
American Indian or Alaska Native
|
0 Participants
n=99 Participants
|
0 Participants
n=107 Participants
|
0 Participants
n=206 Participants
|
|
Race (NIH/OMB)
Asian
|
0 Participants
n=99 Participants
|
0 Participants
n=107 Participants
|
0 Participants
n=206 Participants
|
|
Race (NIH/OMB)
Native Hawaiian or Other Pacific Islander
|
0 Participants
n=99 Participants
|
1 Participants
n=107 Participants
|
1 Participants
n=206 Participants
|
|
Race (NIH/OMB)
Black or African American
|
1 Participants
n=99 Participants
|
1 Participants
n=107 Participants
|
2 Participants
n=206 Participants
|
|
Race (NIH/OMB)
White
|
25 Participants
n=99 Participants
|
26 Participants
n=107 Participants
|
51 Participants
n=206 Participants
|
|
Race (NIH/OMB)
More than one race
|
0 Participants
n=99 Participants
|
0 Participants
n=107 Participants
|
0 Participants
n=206 Participants
|
|
Race (NIH/OMB)
Unknown or Not Reported
|
1 Participants
n=99 Participants
|
0 Participants
n=107 Participants
|
1 Participants
n=206 Participants
|
|
Region of Enrollment
United States
|
27 participants
n=99 Participants
|
28 participants
n=107 Participants
|
55 participants
n=206 Participants
|
PRIMARY outcome
Timeframe: Day 8 (-0/+3 days) after 10 (-2/+6) hours of wear, each study lens typePopulation: Safety Analysis Set with non-missing response
Distance VA was assessed with study lenses in place. VA was collected for each eye separately using logarithmic of the Minimum Angle of Resolution (logMAR) charts. A logMAR acuity of 0.0 corresponds to 20/20 Snellen acuity (normal visual acuity), with a negative value denoting better than 20/20 visual acuity. No formal hypothesis was predefined for the primary endpoint. No inferential testing was performed.
Outcome measures
| Measure |
PRECISION1
n=108 eyes
Verofilcon A contact lenses worn bilaterally (in both eyes) during Period 1 or Period 2, as randomized, for 8 -0/+3 days in a daily disposable modality
|
Biotrue ONEday
n=108 eyes
Nesofilcon A contact lenses worn bilaterally (in both eyes) during Period 1 or Period 2, as randomized, for 8 -0/+3 days in a daily disposable modality
|
|---|---|---|
|
Distance Visual Acuity (VA) With Study Lenses
|
-0.13 logMAR
Standard Deviation 0.08
|
-0.12 logMAR
Standard Deviation 0.08
|
Adverse Events
Pretreatment
PRECISION1 Ocular
PRECISION1 Nonocular
Biotrue ONEday Ocular
Biotrue ONEday Nonocular
Serious adverse events
Adverse event data not reported
Other adverse events
Adverse event data not reported
Additional Information
Results disclosure agreements
- Principal investigator is a sponsor employee Sponsor reserves the right of prior review of any publication or presentation of information related to the study.
- Publication restrictions are in place
Restriction type: OTHER